PARTNERS
About us
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today, Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics, and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, neuropsychiatry, immunology, acute neurology, and neuropathic pain.
Source: Biogen | Investor Relations
.png)
About us
EU40 is the Network of Young Members of the European Parliament. Based in Brussels, it is the organisation that represents MEPs under the age of 40. Created in 2009, EU40 has been active for the past 10 years in the Brussels bubble, accounting for several hundreds of young MEPs. The network extends to key people in the European Commission and the Council. Especially designed to include those in relevant position sharing the same generation, EU40 is perceived as an influential network within the European Union's institutions.
EU40's mission is to serve young Members under the age of 40 and strengthen their role inside the European Parliament. The organisation does this by connecting young politicians with each other and offering them opportunities for publicity and political interaction. EU40 celebrates modern, political communication in the 'Brussels Bubble' and beyond, and has become renowned for its creative and inspirational style, when communicating political content and complex messages.
Contact us about Partnership Opportunities
For more information on partnership opportunities at other FT Live events, get in touch today to see how you can get involved.
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice